Drug Type Biosimilar, Enzyme |
Synonyms- |
Target |
Mechanism ASN inhibitors(Asparagine inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Porton Biopharma Ltd.Startup |
Active Organization Porton Biopharma Ltd.Startup |
Inactive Organization- |
Drug Highest PhaseNDA/BLA |
First Approval Date- |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute Lymphoblastic Leukemia | NDA/BLA | CA | Porton Biopharma Ltd.Startup | 01 Jul 2023 |